These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 27023111
1. Zinc(II)-Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity. Stacy AE, Palanimuthu D, Bernhardt PV, Kalinowski DS, Jansson PJ, Richardson DR. J Med Chem; 2016 May 26; 59(10):4965-84. PubMed ID: 27023111 [Abstract] [Full Text] [Related]
2. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes. Anjum R, Palanimuthu D, Kalinowski DS, Lewis W, Park KC, Kovacevic Z, Khan IU, Richardson DR. Inorg Chem; 2019 Oct 21; 58(20):13709-13723. PubMed ID: 31339305 [Abstract] [Full Text] [Related]
3. Identification of differential anti-neoplastic activity of copper bis(thiosemicarbazones) that is mediated by intracellular reactive oxygen species generation and lysosomal membrane permeabilization. Stefani C, Al-Eisawi Z, Jansson PJ, Kalinowski DS, Richardson DR. J Inorg Biochem; 2015 Nov 21; 152():20-37. PubMed ID: 26335599 [Abstract] [Full Text] [Related]
7. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids. Bacher F, Dömötör O, Chugunova A, Nagy NV, Filipović L, Radulović S, Enyedy ÉA, Arion VB. Dalton Trans; 2015 May 21; 44(19):9071-90. PubMed ID: 25896351 [Abstract] [Full Text] [Related]
12. Increased generation of intracellular reactive oxygen species initiates selective cytotoxicity against the MCF-7 cell line resultant from redox active combination therapy using copper-thiosemicarbazone complexes. Akladios FN, Andrew SD, Parkinson CJ. J Biol Inorg Chem; 2016 Jun 21; 21(3):407-19. PubMed ID: 26951232 [Abstract] [Full Text] [Related]
13. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones. Da Silva JG, Recio Despaigne AA, Louro SR, Bandeira CC, Souza-Fagundes EM, Beraldo H. Eur J Med Chem; 2013 Jul 21; 65():415-26. PubMed ID: 23747809 [Abstract] [Full Text] [Related]
16. In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target. Carcelli M, Tegoni M, Bartoli J, Marzano C, Pelosi G, Salvalaio M, Rogolino D, Gandin V. Eur J Med Chem; 2020 May 15; 194():112266. PubMed ID: 32248006 [Abstract] [Full Text] [Related]
20. Isosteric Replacement of Sulfur to Selenium in a Thiosemicarbazone: Promotion of Zn(II) Complex Dissociation and Transmetalation to Augment Anticancer Efficacy. Kaya B, Gholam Azad M, Suleymanoglu M, Harmer JR, Wijesinghe TP, Richardson V, Zhao X, Bernhardt PV, Dharmasivam M, Richardson DR. J Med Chem; 2024 Jul 25; 67(14):12155-12183. PubMed ID: 38967641 [Abstract] [Full Text] [Related] Page: [Next] [New Search]